Today: 10 March 2026
Subscribe
Browse Category

Earnings Reports 14 January 2026

Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer (PFE) stock rises as CEO calls obesity push a “Viagra”-scale bet, with earnings next in focus

Pfizer shares rose 2% to $25.65 Wednesday after CEO Albert Bourla said the company is “all in on obesity” and plans 10 Phase 3 trials for its Metsera compounds by 2026. Pfizer does not expect revenue growth to return until 2029 as it faces patent expirations and weaker COVID-related sales. AbbVie also announced new obesity drug plans. Novo Nordisk warned of tougher competition in 2026.
14 January 2026
···
Morgan Stanley stock slips as bank earnings spark a pullback ahead of Thursday results

Morgan Stanley stock slips as bank earnings spark a pullback ahead of Thursday results

Morgan Stanley shares fell 1.3% to $180.45 Wednesday, tracking a broader 2.5% drop in the S&P 500 bank index as financial stocks slid ahead of the bank’s quarterly results. The sector faced pressure from early earnings misses and uncertainty over President Trump’s proposed 10% cap on credit card interest rates. Wells Fargo led losses, down 5.6% after missing profit estimates.
14 January 2026
·
Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Uber stock slips after NYC tipping report targets Uber Eats, as earnings date and new profit metrics loom

Uber shares fell 1.3% after New York City accused the company and DoorDash of redesigning their apps to cut delivery workers’ tips by $554 million. The city’s new law requiring apps to offer a tipping option at checkout takes effect Jan. 26, with both firms challenging the rule in court. Uber will shift its key profit metric from adjusted EBITDA to non-GAAP operating income starting in 2026. DoorDash and Lyft shares also declined.
14 January 2026
··
Concentrix stock jumps as CNXC sets 2026 cash-flow target after $1.5 billion goodwill write-down

Concentrix stock jumps as CNXC sets 2026 cash-flow target after $1.5 billion goodwill write-down

Concentrix shares rose 3.9% to $40.71 Wednesday after the company posted Q4 revenue of $2.55 billion and a $1.52 billion goodwill impairment charge. Adjusted profit and cash flow held steady, but BofA and Baird cut price targets, citing margin pressure. Concentrix forecast 2026 revenue of up to $10.18 billion and non-GAAP EPS as high as $12.07.
14 January 2026
··
Infosys stock jumps nearly 9% after INFY lifts FY26 outlook — what investors watch next

Infosys stock jumps nearly 9% after INFY lifts FY26 outlook — what investors watch next

Infosys’ U.S. shares jumped 8.9% to $19.08 after the company raised its fiscal 2026 revenue growth outlook to 3.0%-3.5% and reported $5.099 billion in quarterly revenue. Net profit in India fell 2.2% due to a one-time charge. Large deal wins totaled $4.8 billion. Bank of America raised its price target to $20.50, citing stronger growth in key sectors.
14 January 2026
··
Lumentum stock slides 8% in afternoon trade as tech pulls back; Feb. 3 earnings ahead

Lumentum stock slides 8% in afternoon trade as tech pulls back; Feb. 3 earnings ahead

Lumentum Holdings shares fell 8.1% to $331.93 Wednesday, deepening losses for the Nasdaq-listed optical components maker. The stock swung from an intraday high of $363 to a low of $331.56. Other optics and data-center hardware stocks also declined, including Coherent, Ciena, Arista Networks, and Credo Technology. Lumentum will report fiscal Q2 earnings on Feb. 3 after the market closes.
14 January 2026
···
Qualcomm stock falls again as “glass cloth” supply report rattles chip names ahead of earnings

Qualcomm stock falls again as “glass cloth” supply report rattles chip names ahead of earnings

Qualcomm shares fell 1.5% to $162.73 early Wednesday afternoon, extending a multi-day slide amid concerns over a shortage of high-end glass cloth used in advanced chip packaging. Trading volume reached about 3.4 million shares. Apple and Qualcomm are seeking new suppliers, but industry sources say more capacity may not arrive before late 2027. TSMC reports earnings early Thursday, with Qualcomm’s report due Feb. 4.
14 January 2026
····
CBA shares slide again — here’s what’s spooking Commonwealth Bank investors ahead of earnings

CBA shares slide again — here’s what’s spooking Commonwealth Bank investors ahead of earnings

Commonwealth Bank of Australia shares fell 1.3% to A$152.88 Wednesday, lagging the ASX 200’s 0.14% gain. Morgan Stanley flagged CBA’s 45% valuation premium as a risk for 2026 returns. CBA wage data showed a 0.8% quarterly rise and steady 4.3% unemployment. The Reserve Bank of Australia will announce its next policy decision on Feb. 3.
14 January 2026
··
Snowflake stock slides again after Barclays downgrade; traders eye next earnings date

Snowflake stock slides again after Barclays downgrade; traders eye next earnings date

Snowflake shares dropped 1.4% to $206.52 by midday Wednesday, extending losses after Barclays downgraded the stock and cut its price target to $250. The stock remains below its 200-day moving average after falling 5.1% Tuesday. Broader tech shares also declined, with the Invesco QQQ Trust down 1.6%. Trading volume in Snowflake was heavier than usual following the downgrade.
14 January 2026
····
ServiceNow stock slides near year-low levels as Wall Street sizes up AI push and next earnings

ServiceNow stock slides near year-low levels as Wall Street sizes up AI push and next earnings

ServiceNow shares fell 2.6% to $134.64 by midday Wednesday, extending losses ahead of fourth-quarter results due Jan. 28. Evercore ISI kept its Outperform rating, citing steady demand and interest in the company’s AI tools. Investors are watching for updates on guidance, subscription growth, and the $7.75 billion Armis acquisition.
14 January 2026
····
Goldman Sachs (GS) stock slips as bank selloff deepens ahead of Thursday earnings

Goldman Sachs (GS) stock slips as bank selloff deepens ahead of Thursday earnings

Goldman Sachs shares fell 1.2% to $926.81 midday Wednesday as U.S. bank stocks slid after mixed Q4 earnings, dragging the S&P 500 bank index to a five-week low. The Apple Card transfer to JPMorgan Chase remains in focus, with Goldman expecting a $0.46 per share earnings boost from the deal. JPMorgan took a $2.2 billion credit loss provision tied to the Apple Card acquisition. Goldman reports Q4 results Thursday at 7:30 a.m. Eastern.
14 January 2026
····
Pfizer stock rises as CEO likens obesity-drug boom to Viagra ahead of Feb. 3 earnings

Pfizer stock rises as CEO likens obesity-drug boom to Viagra ahead of Feb. 3 earnings

Pfizer shares rose 1.4% to $25.51 Wednesday morning, outpacing a broader market decline. CEO Albert Bourla said the company misjudged the cash-pay obesity drug market and plans about 10 Phase 3 obesity trials in 2026. Investors are watching for Feb. 3 results and updates on late-stage trial launches. Pfizer expects no revenue growth before 2029 as it faces major patent expirations.
14 January 2026
·····
1 … 112 113 114 115 116 … 227
Go toTop